| Eli Lilly & Co |
LLY
|
3 410 115 |
18.1 |
3 218 |
| AbbVie Inc |
ABBV
|
1 738 076 |
9.2 |
7 356 |
| US BANK MMDA - USBGFS 7 06/01/2031 |
USBGFS7
|
1 611 007 |
8.6 |
1 611 007 |
| Novartis AG |
NVS
|
1 170 488 |
6.2 |
9 194 |
| Alnylam Pharmaceuticals Inc |
ALNY
|
1 036 839 |
5.5 |
2 376 |
| AstraZeneca PLC |
AZN
|
1 000 454 |
5.3 |
10 994 |
| Johnson & Johnson |
JNJ
|
938 348 |
5.0 |
4 602 |
| Ionis Pharmaceuticals Inc |
IONS
|
909 428 |
4.8 |
11 952 |
| Amgen Inc |
AMGN
|
762 840 |
4.1 |
2 260 |
| Bristol-Myers Squibb Co |
BMY
|
742 405 |
3.9 |
16 052 |
| Alkermes PLC |
ALKS
|
631 308 |
3.4 |
22 066 |
| Merck & Co Inc |
MRK
|
629 183 |
3.3 |
6 436 |
| Pfizer Inc |
PFE
|
621 593 |
3.3 |
24 824 |
| Biogen Inc |
BIIB
|
523 796 |
2.8 |
2 988 |
| Regeneron Pharmaceuticals Inc |
REGN
|
521 571 |
2.8 |
690 |
| GSK PLC |
GSK
|
509 274 |
2.7 |
10 792 |
| CRISPR Therapeutics AG |
CRSP
|
508 026 |
2.7 |
10 114 |
| Galectin Therapeutics Inc |
GALT
|
275 439 |
1.5 |
51 484 |
| Beam Therapeutics Inc |
BEAM
|
204 199 |
1.1 |
9 194 |
| Haleon PLC |
HLN
|
133 156 |
0.7 |
13 491 |
| Replimune Group Inc |
REPL
|
126 886 |
0.7 |
13 792 |
| Sandoz Group AG |
SDZNY
|
124 991 |
0.7 |
1 840 |
| Vanda Pharmaceuticals Inc |
VNDA
|
119 155 |
0.6 |
24 824 |
| Intellia Therapeutics Inc |
NTLA
|
113 232 |
0.6 |
13 792 |
| Bicycle Therapeutics PLC |
BCYC
|
87 165 |
0.5 |
13 792 |
| Lantern Pharma Inc |
LTRN
|
83 298 |
0.4 |
27 582 |
| Editas Medicine Inc |
EDIT
|
73 423 |
0.4 |
30 340 |
| GE HealthCare Technologies Inc |
GEHC
|
70 334 |
0.4 |
920 |
| Cash & Other |
Cash&Other
|
39 727 |
0.2 |
39 727 |
| Viatris Inc |
VTRS
|
35 383 |
0.2 |
3 422 |
| Pacific Biosciences of California Inc |
PACB
|
24 495 |
0.1 |
11 034 |
| Allogene Therapeutics Inc |
ALLO
|
22 617 |
0.1 |
18 388 |
| Mural Oncology PLC |
MURA
|
4 615 |
0.0 |
2 208 |